Table 3—

Characteristics of subjects who met ATP III criteria, insulin-resistant subjects who did not meet ATP III criteria, and insulin-sensitive subjects

VariablesATP III+ATP III
Insulin resistantInsulin sensitive
n92045
Age (years)45.6 ± 7.837.2 ± 11.033.0 ± 10.9
BMI (kg/m2)33.6 ± 3.1*28.2 ± 4.524.9 ± 3.5*
Waist circumference (cm)104.2 ± 11.0*93.8 ± 9.382.8 ± 9.0*
Abdominal obesity (%)89.9*30.013.3
Systolic blood pressure (mmHg)123.4 ± 14.1117.2 ± 10.5114.8 ± 11.8
Diastolic blood pressure (mmHg)72.4 ± 10.566.5 ± 8.764.2 ± 9.5
Abnormal blood pressure, (%)55.6*10.013.3
Triglycerides (mg/dl)220.7 ± 88.6*125.6 ± 55.084.6 ± 29.5*
Abnormal triglycerides (%)77.8*25.04.4*
HDL (mg/dl)34.4 ± 5.738.5 ± 11.242.8 ± 11.0
Abnormal HDL (%)100.070.068.9
Fasting glucose (mg/dl)90.7 ± 5.591.7 ± 8.284.0 ± 7.0*
Impaired glucose tolerance (%)25.020.013.3
Glucose disposal rate (mg · kg−1 · min−1)11.1 ± 3.810.6 ± 1.415.6 ± 2.2*
NMR profile (selected)
 Large VLDL concentration (nmol/l)6.5 ± 4.13.9 ± 4.11.4 ± 1.8*
 VLDL size (nm)56.7 ± 8.154.4 ± 10.148.2 ± 8.7*
 Total LDL concentration (nmol/l)1,696 ± 4691,431 ± 4241,155 ± 287*
 Large LDL concentration (nmol/l)353 ± 283479 ± 379620 ± 321
 Small to intermediate LDL (nmol/l)1,332 ± 489938 ± 533523 ± 280*
 LDL size (nm)20.4 ± 0.620.6 ± 0.721.2 ± 0.5*
 Large HDL concentration (μmol/l)2.3 ± 1.84.3 ± 3.37.1 ± 3.3*
 HDL size (nm)8.5 ± 0.28.6 ± 0.39.0 ± 0.4*
  • Data are means ± SD, unless otherwise indicated. ATP+, met ATP criteria; ATP, did not meet ATP III criteria.

  • *

    * P < 0.05 compared with persons who did not meet ATP III criteria (ATP III) and who were insulin resistant with glucose disposal rate <12 mg·kg−1·min−1.